Skip to main navigation
Skip to search
Skip to main content
Penn State Home
Help & FAQ
Home
Researchers
Research output
Research units
Equipment
Grants & Projects
Prizes
Activities
Search by expertise, name or affiliation
Coverage for hepatitis C drugs in Medicare Part D
Jeah Kyoungrae Jung
, Roger Feldman
, Chelim Cheong
, Ping Du
,
Douglas Leslie
Health Policy and Administration
Department of Public Health Sciences
Penn State Cancer Institute
Cancer Institute, Cancer Control
Department of Medicine
Division of Health Services and Behavioral Research
Department of Psychiatry and Behavioral Health
Center for Cannabis and Natural Product Pharmaceuticals (CCNPP)
Research output
:
Contribution to journal
›
Article
›
peer-review
29
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Coverage for hepatitis C drugs in Medicare Part D'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Hepatitis C Virus
100%
Medicare Part D
100%
Out-of-pocket Expenditure
37%
Treatment Course
25%
Subsidies
25%
Financial Burden
25%
Management Tools
12%
Patient Access
12%
Medicare
12%
Sectional Analysis
12%
Formulary
12%
Utilization Management
12%
Drug Users
12%
Cost Sharing
12%
Prior Authorization
12%
Benefit Design
12%
Baby Boomers
12%
Coinsurance
12%
Low-income Subsidy
12%
Fiscal Pressure
12%
Medicine and Dentistry
Hepatitis C Virus
100%
Hepatitis C
100%
Medicare
100%
Cross Sectional Study
12%
Cost Sharing
12%
Pharmacology, Toxicology and Pharmaceutical Science
Hepatitis C Virus
100%
Hepatitis C
100%
Cross Sectional Study
12%